Injected arthritis drug reduces risk of death from Covid-19 by 4%, study finds
The NHS will start using an arthritis drug to treat hospitalised Covid patients after a breakthrough study found it cuts the risk of dying. Tocilizumab can reduce swelling inside the organs and, when combined with steroid dexamethasone slashes the odds of death by a third. Oxford University scientists behind the RECOVERY trial found the drug … Read more